Business Description
Entheon Biomedical Corp
NAICS : 325410
SIC : 3741
ISIN : CA29383X1033
Share Class Description:
ENTBF: Ordinary SharesCompare
Compare
Traded in other countries / regions
ENBI.X.Canada1XU.GermanyENTBF.USA IPO Date
2020-11-17Description
Entheon Biomedical Corp is a biotechnology research and development company focused on treating addiction and substance use disorders.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.79 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 65.5 | |||||
3-Year EPS without NRI Growth Rate | 61.2 | |||||
3-Year FCF Growth Rate | 58.9 | |||||
3-Year Book Growth Rate | -39.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
14-Day RSI | 0.02 | |||||
12-1 Month Momentum % | 16.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.65 | |||||
Quick Ratio | 4.65 | |||||
Cash Ratio | 4.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.9 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -74.21 | |||||
ROA % | -67.48 | |||||
ROIC % | -2928.57 | |||||
3-Year ROIIC % | -16330 | |||||
ROC (Joel Greenblatt) % | -2609.09 | |||||
ROCE % | -76.62 | |||||
Moat Score | 1 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PB Ratio | 3.13 | |||||
EV-to-EBIT | -1.48 | |||||
EV-to-EBITDA | -1.48 | |||||
EV-to-FCF | -1.65 | |||||
Earnings Yield (Greenblatt) % | -67.57 | |||||
FCF Yield % | -37.09 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ENTBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Entheon Biomedical Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | 1.3805 | ||
| 3-Year Sharpe Ratio | 0.12 | ||
| 3-Year Sortino Ratio | 0.22 | ||
| Volatility % | 57.1 | ||
| 14-Day RSI | 0.02 | ||
| 14-Day ATR ($) | 0.004014 | ||
| 20-Day SMA ($) | 0.015061 | ||
| 12-1 Month Momentum % | 16.82 | ||
| 52-Week Range ($) | 0.0004 - 0.1038 | ||
| Shares Outstanding (Mil) | 13.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Entheon Biomedical Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Entheon Biomedical Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2024-03-01 | 0.09 (+0.00%) |
Show
Entries
Entheon Biomedical Corp Frequently Asked Questions
What is Entheon Biomedical Corp(ENTBF)'s stock price today?
The current price of ENTBF is $0.00. The 52 week high of ENTBF is $0.10 and 52 week low is $0.00.
When is next earnings date of Entheon Biomedical Corp(ENTBF)?
The next earnings date of Entheon Biomedical Corp(ENTBF) is .
Does Entheon Biomedical Corp(ENTBF) pay dividends? If so, how much?
Entheon Biomedical Corp(ENTBF) does not pay dividend.
Guru Commentaries on OTCPK:ENTBF
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| KCSA Strategic Communications to Host Inaugural KCSA Psychedelics Investor Conference on January 26-27, 2021 | 2021-01-11 |
Articles on Entheon Biomedical Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers